ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

23,00
0,00
(0,00%)
Fermé 06 Janvier 5:30PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
23,00
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
23,00 Plage de 52 semaines 23,00
Cap du marché
Clôture Veille
23,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
9 679
Actions en circulation
657 954 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,32
Bénéfice par action (BPA)
-0,38
Chiffre d'affairess
59,27M
Bénéfice net
-248,59M

À propos de Alligator Bioscience Ab

Secteur
Noncomml Resh Organizations
Industrie
Noncomml Resh Organizations
Siège social
Lund, Swe
Fondé
-
Alligator Bioscience Ab est coté dans le secteur Noncomml Resh Organizations de la London Stock Exchange avec le ticker 0RK9. Le dernier cours de clôture d'Alligator Bioscience Ab était de SEK23,00. Au cours de la dernière année, les actions de Alligator Bioscience Ab ont été négociées dans une fourchette de prix de SEK 23,00 à SEK 23,00.

Alligator Bioscience Ab compte actuellement 657 954 000 actions en circulation. La capitalisation boursière d'Alligator Bioscience Ab est de SEK15,13 milliard. Alligator Bioscience Ab a un ratio cours/bénéfice (ratio PE) de -1.32.

0RK9 Dernières nouvelles

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10023232300DE
4002323231306223DE
1200232323967923DE
2600232323479823DE
5200232323352323DE
15600232323197323DE
26000232323200423DE

0RK9 - Frequently Asked Questions (FAQ)

What is the current Alligator Bioscience Ab share price?
The current share price of Alligator Bioscience Ab is SEK 23,00
How many Alligator Bioscience Ab shares are in issue?
Alligator Bioscience Ab has 657 954 000 shares in issue
What is the market cap of Alligator Bioscience Ab?
The market capitalisation of Alligator Bioscience Ab is SEK 15,13B
What is the 1 year trading range for Alligator Bioscience Ab share price?
Alligator Bioscience Ab has traded in the range of SEK 23,00 to SEK 23,00 during the past year
What is the PE ratio of Alligator Bioscience Ab?
The price to earnings ratio of Alligator Bioscience Ab is -1,32
What is the cash to sales ratio of Alligator Bioscience Ab?
The cash to sales ratio of Alligator Bioscience Ab is 5,55
What is the reporting currency for Alligator Bioscience Ab?
Alligator Bioscience Ab reports financial results in SEK
What is the latest annual turnover for Alligator Bioscience Ab?
The latest annual turnover of Alligator Bioscience Ab is SEK 59,27M
What is the latest annual profit for Alligator Bioscience Ab?
The latest annual profit of Alligator Bioscience Ab is SEK -248,59M
What is the registered address of Alligator Bioscience Ab?
The registered address for Alligator Bioscience Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81
What is the Alligator Bioscience Ab website address?
The website address for Alligator Bioscience Ab is www.alligatorbioscience.se
Which industry sector does Alligator Bioscience Ab operate in?
Alligator Bioscience Ab operates in the NONCOMML RESH ORGANIZATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées